A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran

Digestive and Liver Disease

Volumn 40, Issue 6, 2008, Pages 412-417

  Rezailashkajani, M ^a   Roshandel, D ^a   Shafaee, S ^a   Zali, M R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Developing countries; Dyspepsia; Economics; Gastro oesophageal reflux disease; Iran

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; BISMUTH; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ABSENTEEISM; ADULT; ARTICLE; ATTITUDE TO ILLNESS; CLINICAL FEATURE; CONSULTATION; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG COST; DYSPEPSIA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEARTBURN; HOSPITALIZATION; HUMAN; IRAN; LABORATORY TEST; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SAMPLING;

ADULT; COST OF ILLNESS; COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HUMANS; IRAN; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 42649142252     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.01.014     Document Type: Article

References (23)

1. Dent J., El-Serag H.B., Wallander M.A., and Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54 (2005) 710-717
2. Kang J.Y. Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 20 (2004) 705-717
3. Cantu P., Savojardo D., Carmagnola S., and Penagini R. Impact of referral for gastro-oesophageal reflux disease on the workload of an academic Gastroenterology Unit. Dig Liver Dis 37 (2005) 735-740
4. El-Serag H.B., and Talley N.J. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 19 (2004) 643-654
5. Talley N.J., Stanghellini V., Heading R.C., Koch K.L., Malagelada J.R., and Tytgat G.N. Functional gastroduodenal disorders. Gut 45 Suppl. 2 (1999) II37-II42
6. Lu C.L., Lang H.C., Chang F.Y., Chen C.Y., Luo J.C., Wang S.S., et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol 40 (2005) 402-411
7. Minocha A., Wigington W.C., and Johnson W.D. Detailed characterization of epidemiology of uninvestigated dyspepsia and its impact on quality of life among African Americans as compared to Caucasians. Am J Gastroenterol 101 (2006) 336-342
8. Reshetnikov O.V., Kurilovich S.A., Denisova D.V., Zavyalova L.G., and Tereshonok I.N. Prevalence of dyspepsia and irritable bowel syndrome among adolescents of Novosibirsk, western Siberia. Int J Circumpolar Health 60 (2001) 253-257
9. Talley N.J., Boyce P., and Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 42 (1998) 690-695
10. Westbrook J.I., and Talley N.J. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 37 (2002) 917-923
11. Khoshbaten M. Gastro-esophageal reflux disease in northwestern Tabriz, Iran. Indian J Gastroenterol 22 (2003) 138-139
12. Joish V.N., Donaldson G., Stockdale W., Oderda G.M., Crawley J., Sasane R., et al. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 21 (2005) 535-544
13. Kurata J.H., Nogawa A.N., and Everhart J.E. A prospective study of dyspepsia in primary care. Dig Dis Sci 47 (2002) 797-803
14. Agreus L., and Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 20 (2002) 347-355
15. Leodolter A., Nocon M., Kulig M., Willich S.N., Malfertheiner P., and Labenz J. Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study. World J Gastroenterol 11 (2005) 7148-7151
16. Stanghellini V., Cogliandro R., Cogliandro L., De Giorgio R., Barbara G., and Corinaldesi R. Unsolved problems in the management of patients with gastro-oesophageal reflux disease. Dig Liver Dis 35 (2003) 843-848
17. Meineche-Schmidt V., and Jorgensen T. Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia. Dig Liver Dis 34 (2002) 332-338
18. Schwenkglenks M., Marbet U.A., and Szucs T.D. Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz Praventivmed 49 (2004) 51-61
19. Willich S.N., Nocon M., Kulig M., Jaspersen D., Labenz J., Meyer-Sabellek W., et al. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther 23 (2006) 371-376
20. Armstrong D., Bennett J.R., Blum A.L., Dent J., De Dombal F.T., Galmiche J.P., et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111 (1996) 85-92
21. IRTEB website. Available from: http://www.irteb.com [cited 2006 August].
22. The World Bank website. Available from: http://www.worldbank.org [cited 2006 August].
23. Rezailashkajani M., Roshandel D., Shafaee S., and Zali M.R. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Eur J Gastroenterol Hepatol 19 (2007) 499-506